Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The evolving landscape of biologic therapies for atopic dermatitis: Present and future perspective
Eden David, Benjamin Ungar, Yael Renert‐Yuval, et al.
Clinical & Experimental Allergy (2023) Vol. 53, Iss. 2, pp. 156-172
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Atopic dermatitis
Emma Guttman‐Yassky, Yael Renert‐Yuval, Patrick M. Brunner
The Lancet (2025) Vol. 405, Iss. 10478, pp. 583-596
Closed Access | Times Cited: 3
Dupilumab-associated head and neck dermatitis shows a pronounced type 22 immune signature mediated by oligoclonally expanded T cells
Christine Bangert, Natalia Alkon, Sumanth Chennareddy, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Dupilumab’s Impact on Blood Parameters in Nasal Polyposis: 18-Month Follow-Up in Real Life
Antonella Loperfido, Andrea Ciofalo, Carlo Cavaliere, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-10
Open Access | Times Cited: 13
Management of Infant Atopic Eczema to Prevent Severe Eczema and Food Allergy
Kiwako Yamamoto‐Hanada, Yukihiro Ohya
Clinical & Experimental Allergy (2024) Vol. 54, Iss. 9, pp. 669-681
Closed Access | Times Cited: 5
Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease
Shivam A. Zaver, Mrinal K. Sarkar, Shaun Egolf, et al.
JCI Insight (2023) Vol. 8, Iss. 18
Open Access | Times Cited: 12
Clinical aspects and management of chronic itch
Claudia Zeidler, Ulrike Raap, Felix Witte, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 1, pp. 1-10
Closed Access | Times Cited: 11
Biomarkers in Atopic Dermatitis
Florence Libon, Juliette Caron, Arjen Nikkels
Dermatology and Therapy (2024) Vol. 14, Iss. 7, pp. 1729-1738
Open Access | Times Cited: 4
Topical Anti‐Inflammatory Treatments for Eczema: A Cochrane Systematic Review and Network Meta‐Analysis
S. Lax, Eleanor Van Vogt, Bridget Candy, et al.
Clinical & Experimental Allergy (2024) Vol. 54, Iss. 12, pp. 960-972
Open Access | Times Cited: 4
The APOLO Study: A Cross-Sectional Analysis of Disease Characteristics and Patient Burden in Moderate-to-Severe Atopic Dermatitis in Portugal
Bruno Kosa Lino Duarte, Pedro Mendes‐Bastos, Joana Antunes, et al.
Dermatology and Therapy (2025)
Open Access
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis
Amalie Thorsti Møller Rønnstad, Christopher G. Bunick, Raj Chovatiya, et al.
American Journal of Clinical Dermatology (2025)
Closed Access
Effects of Malassezia globosa on the Expression of Thymic Stromal Lymphopoietin and Differentiation of T Helper Cells in MC903‐Induced Atopic Dermatitis Mouse Model
Xin Zhou, Zijian Cheng, Qintai Yang, et al.
International Journal of Microbiology (2025) Vol. 2025, Iss. 1
Open Access
CLA+ memory T cells in atopic dermatitis
Lídia Sans‐de San Nicolàs, Tali Czarnowicki, Mübeccel Akdiş, et al.
Allergy (2023) Vol. 79, Iss. 1, pp. 15-25
Open Access | Times Cited: 9
Readability of Patient Electronic Materials for Atopic Dermatitis in 23 Languages: Analysis and Implications for Dermatologists
Tomasz Skrzypczak, Anna Skrzypczak, Jacek C. Szepietowski
Dermatology and Therapy (2024) Vol. 14, Iss. 3, pp. 671-684
Open Access | Times Cited: 3
IL-13 inhibition in the treatment of atopic dermatitis – new and emerging biologic agents
Carlos Eduardo Garcez Teixeira, Orhan Yilmaz, Diana Bernardo, et al.
Journal of International Medical Research (2024) Vol. 52, Iss. 11
Open Access | Times Cited: 3
Diseases from the Spectrum of Dermatitis and Eczema: Can “Omics” Sciences Help with Better Systematics and More Accurate Differential Diagnosis?
Radosław Śpiewak
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10468-10468
Open Access | Times Cited: 8
Patients’ preferences for systemic treatment of atopic dermatitis: safety and efficacy count the most
Marthe‐Lisa Schaarschmidt, Daniel Kromer, Phoebe Wellmann, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 2
Upadacitinib for Refractory Paediatric Atopic Dermatitis: A Real‐World Study on Effectiveness and Safety in Dupilumab Nonresponders
Mutong Zhao, Yi Zhuang, Yuan Liang, et al.
Clinical & Experimental Allergy (2024) Vol. 54, Iss. 9, pp. 694-696
Closed Access | Times Cited: 2
Interleukin-1α inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studies
Eric L. Simpson, Emma Guttman‐Yassky, Jeff S. Pawlikowski, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 8
Open Access | Times Cited: 2
Burden of Disease and Unmet Needs in the Diagnosis and Management of Atopic Dermatitis in Diverse Skin Types in Australia
Ashling Courtney, Diego J. Lopez, Adrian J. Lowe, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3812-3812
Open Access | Times Cited: 6
Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
Silvia Ferrucci, Giovanni Casazza, Martina Zussino, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 20, pp. 6575-6575
Open Access | Times Cited: 5
Proteomic alterations in patients with atopic dermatitis
Ashley Obi, Camille Rothenberg‐Lausell, Sophia Levit, et al.
Expert Review of Proteomics (2024) Vol. 21, Iss. 5-6, pp. 247-257
Closed Access | Times Cited: 1
Atopic dermatitis: real-life experience with tralokinumab after dupilumab failure: a case series
Patrícia Amoedo, Gilberto Pires da Rosa, Teresa Baudrier, et al.
Anais Brasileiros de Dermatologia (2024) Vol. 99, Iss. 5, pp. 721-724
Open Access | Times Cited: 1
Pathomechanism of Adverse Reactions to Biological Treatment of Inflammatory Skin Conditions
Lichen Li, Dean J. Naisbitt, Yonghu Sun, et al.
Clinical & Experimental Allergy (2024) Vol. 54, Iss. 12, pp. 973-983
Open Access | Times Cited: 1
ERK hyperactivation in epidermal keratinocytes impairs intercellular adhesion and drives Grover disease pathology
Cory L. Simpson, Afua Tiwaa, Shivam A. Zaver, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Causal relationship and mediation effects of immune cells and plasma metabolites in atopic dermatitis: A Mendelian randomization study
Kaiwen Yang, Jianqiao Zhong, Dingchang Xian
Medicine (2024) Vol. 103, Iss. 41, pp. e39932-e39932
Open Access
Page 1 - Next Page

Scroll to top